Cargando…
Homocysteine and cognitive impairment; a case series in a General Practice setting
BACKGROUND: An elevated blood level of homocysteine is a risk factor for cognitive impairment and dementia. Homocysteine can be lowered by folate and/or vitamin B(12 )supplementation; antioxidants might also be required for optimal reduction in neurovascular tissue. This report presents clinical and...
Autor principal: | McCaddon, Andrew |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1395322/ https://www.ncbi.nlm.nih.gov/pubmed/16480506 http://dx.doi.org/10.1186/1475-2891-5-6 |
Ejemplares similares
-
Homocysteine—a retrospective and prospective appraisal
por: McCaddon, Andrew, et al.
Publicado: (2023) -
Homocysteine and Dementia: An International Consensus Statement(1)
por: Smith, A. David, et al.
Publicado: (2018) -
COVID-19: A methyl-group assault?
por: McCaddon, Andrew, et al.
Publicado: (2021) -
Alzheimer’s Amyloidopathy: An Alternative Aspect
por: Regland, Björn, et al.
Publicado: (2019) -
Examining the Diagnosis and Treatment Experiences of People Living With Autoimmune Gastritis and Pernicious Anemia
por: Cotton, Martine, et al.
Publicado: (2023)